These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant. Refaie AF, Mahmoud KM, Ismail AM, Sheashaa HA, Kamal AI, Ghoneim MA. Exp Clin Transplant; 2011 Oct 24; 9(5):295-301. PubMed ID: 21967254 [Abstract] [Full Text] [Related]
15. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Khwaja K, Asolati M, Harmon J, Melancon JK, Dunn T, Gillingham K, Kandaswamy R, Humar A, Gruessner R, Payne W, Najarian J, Dunn D, Sutherland D, Matas AJ. Am J Transplant; 2004 Jun 24; 4(6):980-7. PubMed ID: 15147433 [Abstract] [Full Text] [Related]
18. Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience. Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Tawab KA, Balaha MA, Abraham M, Said T, Nair MP, Al-Waheeb S, Al-Muzairai I, Nampoory MR. Transplant Proc; 2009 Jun 24; 41(5):1666-70. PubMed ID: 19545704 [Abstract] [Full Text] [Related]
19. Short-term results under three different immunosuppressive regimens at one center. Schaefer HM, Kizilisik AT, Feurer I, Nylander WA, Langone AJ, Helderman JH, Shaffer D. Transplant Proc; 2006 Dec 24; 38(10):3466-7. PubMed ID: 17175305 [Abstract] [Full Text] [Related]
20. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Höcker B, Tönshoff B. Paediatr Drugs; 2011 Feb 01; 13(1):49-69. PubMed ID: 21162600 [Abstract] [Full Text] [Related] Page: [Next] [New Search]